VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,056,000 | -23.2% | 417,100 | +29.9% | 0.21% | +28.2% |
| Q3 2016 | $7,885,000 | +92.1% | 321,200 | +57.6% | 0.16% | +18.1% |
| Q2 2016 | $4,104,000 | +54.8% | 203,752 | +102.0% | 0.14% | +76.9% |
| Q1 2016 | $2,652,000 | +53.5% | 100,852 | +1059.2% | 0.08% | +62.5% |
| Q1 2015 | $1,728,000 | -87.8% | 8,700 | -92.8% | 0.05% | -95.0% |
| Q4 2013 | $14,111,000 | -18.1% | 120,200 | -27.2% | 0.96% | -38.1% |
| Q3 2013 | $17,235,000 | -48.0% | 165,200 | -57.1% | 1.56% | -54.2% |
| Q2 2013 | $33,141,000 | – | 385,000 | – | 3.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |